02403nas a2200241 4500000000100000008004100001260003700042653005700079100001400136700001500150700001600165700001600181700001400197700001500211700001300226700001300239245007200252856007700324300000800401490000700409520172000416022002502136 2023 d bPan American Health Organization10aPublic Health, Environmental and Occupational Health1 aGyorkos T1 aNicholls R1 aMontresor A1 aLuciañez A1 aCasapia M1 aSt-Denis K1 aBlouin B1 aJoseph S00aEliminating morbidity caused by neglected tropical diseases by 2030 uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976266/pdf/rpsp-47-e16.pdf a1-80 v473 a
The objective of this manuscript is to provide selective examples of the work of the Pan American Health Organization/World Health Organization (PAHO/WHO) Collaborating Centre for Research and Training in Parasite Epidemiology and Control which contribute to the WHO goal of eliminating neglected tropical diseases by 2030. This PAHO/WHO CC specifically aligns its activities with the Sustainable Development Goals and with the goals outlined in the WHO Road Map for Neglected Tropical Diseases 2021-2030. Its role is to contribute to advancing global action on NTDs, primarily through policy development and knowledge translation. Three important projects have recently been completed: 1. Finalizing the Monitoring and Evaluation Framework for the NTD Road Map (published May 2021; this PAHO/WHO CC was a member of the working group); 2. Developing new guidelines for the preventive chemotherapy of Taenia solium taeniasis (published September 2021; this PAHO/WHO CC was co-Chair; and 3. Formulating a policy brief on deworming for adolescent girls and women of reproductive age (published January 2022; this PAHO/WHO CC is co-lead). These projects are the result of the integration of expertise and experience from multiple partners, including from PAHO and WHO (where both organizations provided key leadership), this PAHO/WHO CC, government ministries, civil society organizations and universities, among others. In conclusion, this PAHO/WHO CC contributes timely guidance to country-led evidence-informed public health policy, to cost-effective program implementation and to the identification of priority research topics – all focused, ultimately, on eliminating NTD-attributable morbidity by 2030.
a1020-4989, 1680-5348